CMG Pharmaceutical Co Ltd banner
C

CMG Pharmaceutical Co Ltd
KOSDAQ:058820

Watchlist Manager
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Watchlist
Price: 1 800 KRW -0.66% Market Closed
Market Cap: ₩266.1B

Balance Sheet

Balance Sheet Decomposition
CMG Pharmaceutical Co Ltd

Balance Sheet
CMG Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1 829
355
2
11
609
2 850
2 714
6 233
1 063
2 447
1 152
4 674
21 705
8 827
2 566
2 149
3 799
13 464
18 571
8 044
9
0
1 243
2 588
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 243
2 588
Cash Equivalents
1 829
355
2
11
609
2 850
2 714
6 233
1 063
2 447
1 152
4 674
21 705
8 827
2 566
2 149
3 799
13 464
18 571
8 044
9
0
0
0
Short-Term Investments
6
240
381
0
1 500
0
2 800
130
500
8
8
30 000
0
0
5 000
57 014
53 250
41 000
101 003
101 732
85 582
73 357
67 585
74 206
Total Receivables
418
763
612
120
1 066
2 467
3 081
8 540
5 403
7 553
10 596
9 435
11 493
13 821
12 668
12 759
15 673
17 706
21 213
20 526
21 016
34 705
24 633
32 524
Accounts Receivables
14
26
72
33
278
2 401
2 235
7 409
4 362
5 550
8 929
8 747
11 074
13 486
12 354
12 583
15 312
17 581
20 632
19 021
19 646
22 470
24 138
32 411
Other Receivables
404
737
540
87
788
66
846
1 131
1 041
2 003
1 667
688
419
335
314
176
361
125
581
1 505
1 370
12 235
496
112
Inventory
14 052
8 443
7 451
3 448
223
0
313
1 710
2 429
2 783
2 743
2 955
4 619
4 913
5 456
6 394
7 905
8 573
9 049
15 047
13 196
21 270
20 570
23 788
Other Current Assets
55
73
88
313
50
80
43
112
432
251
841
44
393
740
581
457
601
627
748
632
929
1 282
1 707
1 754
Total Current Assets
16 359
9 874
8 534
3 893
3 449
5 397
8 952
16 725
9 827
13 041
15 341
47 109
38 210
28 301
26 272
78 772
81 227
81 370
150 584
145 981
125 482
135 070
115 737
134 859
PP&E Net
3 789
3 117
643
476
4 006
2 263
7 133
11 104
10 161
10 317
9 708
9 307
10 805
18 834
17 822
16 906
16 183
17 269
24 119
29 741
30 516
37 472
50 711
77 977
PP&E Gross
3 789
3 117
643
476
4 006
2 263
7 133
11 104
10 161
10 317
9 708
9 307
10 805
18 834
17 822
16 906
16 183
17 269
24 119
29 741
30 516
37 472
50 711
77 977
Accumulated Depreciation
2 129
1 732
217
411
630
30
60
339
1 578
1 557
2 406
3 378
4 245
5 637
7 323
9 036
10 496
11 819
13 516
15 537
17 293
18 257
19 369
21 404
Intangible Assets
327
268
57
89
159
0
146
188
1 728
2 593
1 403
155
6 356
10 296
11 766
13 547
7 596
8 072
11 075
12 059
12 706
14 387
17 302
19 280
Goodwill
0
0
0
0
0
0
0
308
233
0
0
0
0
0
0
0
0
0
0
0
0
0
2 274
2 274
Note Receivable
3
676
674
585
533
0
50
45
0
0
0
0
0
0
0
0
0
0
0
0
7 080
111
80
23 632
Long-Term Investments
233
334
14
4
3
820
2 256
2 500
613
610
500
286
253
202
202
1 303
4 154
4 657
4 003
5 162
21 145
22 994
52 563
46 463
Other Long-Term Assets
196
1 132
1 141
132
130
1 550
3 537
3 686
274
215
353
251
289
435
471
451
409
3 012
2 461
2 413
2 245
3 226
3 431
1 048
Other Assets
0
0
0
0
0
0
0
308
233
0
0
0
0
0
0
0
0
0
0
0
0
0
2 274
2 274
Total Assets
20 908
N/A
15 401
-26%
11 063
-28%
5 179
-53%
8 280
+60%
10 030
+21%
22 074
+120%
34 557
+57%
22 836
-34%
26 776
+17%
27 305
+2%
57 108
+109%
55 913
-2%
58 068
+4%
56 533
-3%
110 980
+96%
109 568
-1%
114 380
+4%
192 243
+68%
195 356
+2%
199 175
+2%
213 260
+7%
242 098
+14%
303 437
+25%
Liabilities
Accounts Payable
637
260
1 048
35
14
1 055
324
1 704
1 576
1 489
1 481
2 671
3 912
4 720
4 844
5 689
7 002
4 163
4 328
5 591
5 038
11 245
9 197
12 013
Accrued Liabilities
207
878
240
1 000
2 859
0
0
433
1 502
414
357
477
452
526
1 246
673
1 911
1 378
2 054
2 026
2 124
3 179
3 568
3 424
Short-Term Debt
10 579
7 448
3 223
1 533
0
0
0
0
5 000
0
0
0
0
5
6
0
0
0
0
0
0
0
880
880
Current Portion of Long-Term Debt
0
0
0
0
75
0
0
28
13
1 584
4 134
2 233
0
1 538
0
0
0
0
130
422
412
356
206
43 409
Other Current Liabilities
178
65
86
33
673
1 916
1 049
806
959
1 834
1 661
1 413
1 136
1 930
2 754
2 775
1 971
2 955
2 794
5 610
6 155
7 122
10 678
14 919
Total Current Liabilities
11 601
8 650
4 597
2 600
3 621
2 971
1 372
2 971
9 050
5 321
7 634
6 793
5 500
8 719
8 850
9 137
10 884
8 495
9 306
13 649
13 729
21 903
24 529
74 645
Long-Term Debt
0
0
0
0
1 225
0
0
5 750
3 355
2 000
0
0
1 415
0
0
0
0
0
157
69
98
6 356
25 033
35 676
Other Liabilities
517
216
32
19
15
0
0
1 082
1 019
1 050
1 637
18 724
0
346
876
735
740
1 903
2 622
506
645
48
2 303
3 574
Total Liabilities
12 119
N/A
8 867
-27%
4 630
-48%
2 619
-43%
4 861
+86%
2 971
-39%
1 372
-54%
9 804
+615%
13 424
+37%
8 371
-38%
9 271
+11%
25 517
+175%
6 915
-73%
9 066
+31%
9 726
+7%
9 872
+2%
11 624
+18%
10 398
-11%
12 085
+16%
14 225
+18%
14 472
+2%
28 307
+96%
51 866
+83%
113 895
+120%
Equity
Common Stock
4 900
4 900
4 900
4 900
6 600
2 464
6 327
7 817
8 292
20 588
21 847
33 013
43 313
43 313
44 149
54 354
54 444
54 444
69 446
69 446
69 446
69 446
69 446
69 446
Retained Earnings
110
2 144
2 246
6 119
8 677
12 088
12 978
18 256
37 358
43 707
45 161
52 380
52 202
52 394
56 414
54 547
3 398
2 309
5 055
5 638
8 791
9 000
14 219
13 894
Additional Paid In Capital
3 779
3 779
3 779
3 779
5 496
16 710
27 379
35 737
38 478
41 558
41 361
50 959
57 682
58 084
59 072
101 290
46 898
47 229
105 657
106 047
104 827
104 641
104 641
104 889
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
35
13
1
1
1
1
0
0
0
0
0
403
632
632
210
Treasury Stock
0
0
0
0
0
28
28
544
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
87 414
0
0
204
0
0
11
0
0
0
0
1 237
1 234
1 294
1 103
Total Equity
8 789
N/A
6 535
-26%
6 433
-2%
2 560
-60%
3 419
+34%
7 059
+106%
20 701
+193%
24 753
+20%
9 412
-62%
18 405
+96%
18 034
-2%
31 591
+75%
48 997
+55%
49 003
+0%
46 807
-4%
101 108
+116%
97 944
-3%
103 982
+6%
180 158
+73%
181 131
+1%
184 702
+2%
184 953
+0%
190 233
+3%
189 542
0%
Total Liabilities & Equity
20 908
N/A
15 401
-26%
11 063
-28%
5 179
-53%
8 280
+60%
10 030
+21%
22 074
+120%
34 557
+57%
22 836
-34%
26 776
+17%
27 305
+2%
57 108
+109%
55 913
-2%
58 068
+4%
56 533
-3%
110 980
+96%
109 568
-1%
114 380
+4%
192 243
+68%
195 356
+2%
199 175
+2%
213 260
+7%
242 098
+14%
303 437
+25%
Shares Outstanding
Common Shares Outstanding
8
8
8
8
11
13
15
18
19
48
51
76
100
100
102
117
117
117
139
139
139
139
139
139
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett